Fredun Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on May 30, 2017, has transacted the Final Dividend at the rate of 6% to Equity Shareholders was approved by the Board and decided to be proposed for Shareholders approval at the upcoming Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.